Official recall notice

FDA DrugClass IINotable

FDA Recall: Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for:

Recall date
2026-09-02
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Subpotent Drug

Product description

Subpotent Drug

Affected products

Lot #: D2402016, D2402017, Exp. Date 08/31/2026

Verify with the official notice →
Share:

Related Recalls

2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Ac
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451-
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for:
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457
ACCORD HEALTHCARE, INC.
FDA Recall: Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for: (2026) | WatchRecall